A pharmaceutical composition containing (A) glycopyrrolate； and (B) a compound of formula Iin free or salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the specification, together with at least one pharmaceutically acceptable carrier. The composition is useful in the treatment of inflammatory or obstructive airways diseases.
